All these findings suggest that NHERF1 may suppress Wnt/β-catenin signaling activation via a decrease in ACTN4 levels to elicit anti-proliferation and tumor-suppressive effects in cervical cancer. The gene discussed is NHERF1; the disease is cervical cancer.